Want to see AU:HIQ full AI Analyst Report?
HIQ Stock Chart & Stats
AU$0.02
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.02
AU$0.00(0.00%)
Day’s Range― - ―
52-Week Range<AU$0.01 - AU$0.04
Previous CloseN/A
Volume134.14K
Average Volume (3M)233.78K
Market Cap
AU$5.29M
Enterprise ValueAU$5.63M
Total Cash (Recent Filing)AU$359.17K
Total Debt (Recent Filing)AU$1.53M
Price to Earnings (P/E)―
Beta0.04
Next Earnings
Aug 28, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding756,219,300
10 Day Avg. Volume147,164
30 Day Avg. Volume233,782
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)-1.60
Price to Sales (P/S)3.20
P/FCF Ratio-1.38
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Recurring Revenue ModelHitIQ’s business mixes upfront hardware sales with recurring software and analytics subscriptions, creating predictable, annuity-style revenue. Over 2–6 months this supports cash visibility, enables customer lifetime value optimization, and provides a platform for scalable service upsells and retention-driven margin expansion.
Specialized Product Offering And Domain FocusA focused product — instrumented mouthguards plus analytics — gives HitIQ a clear niche in head-impact monitoring. This specialization builds domain expertise, higher switching costs for teams, and the potential for data network effects as deployed sensors and historical datasets increase the value of analytics over time.
Cash Conversion Efficiency SignalThe reported free cash flow to net income ratio (~1.01) suggests HitIQ can convert accounting losses into some real cash preservation through working-capital actions or capital discipline. That efficiency helps extend runway and supports operational continuity while management pursues scaling or restructuring initiatives.
Bears Say
Severely Negative MarginsExtremely negative gross and net margins indicate that HitIQ’s current unit economics are deeply unprofitable. Without durable margin improvement, the business cannot sustainably fund operations or scale; structural cost or pricing changes are required to achieve positive cash generation and long-term viability.
Negative Equity And Leverage ConcernsNegative shareholders’ equity and an unfavorable debt-to-equity metric signal balance-sheet fragility. This reduces financial flexibility, increases reliance on external financing or dilutive equity raises, and constrains the company’s ability to invest in growth or withstand industry shocks over the medium term.
Persistent Negative Operating And Free Cash FlowSustained negative operating and free cash flows erode liquidity and force dependence on external funding. Over months this limits the company’s ability to expand sales, R&D, or customer support, increases refinancing risk, and raises the likelihood of strategic compromises if cash burn is not materially reduced.
HitIQ Limited News
HIQ FAQ
What was HitIQ Limited’s price range in the past 12 months?
HitIQ Limited lowest share price was <AU$0.01 and its highest was AU$0.04 in the past 12 months.
What is HitIQ Limited’s market cap?
HitIQ Limited’s market cap is AU$5.29M.
When is HitIQ Limited’s upcoming earnings report date?
HitIQ Limited’s upcoming earnings report date is Aug 28, 2026 which is in 57 days.
How were HitIQ Limited’s earnings last quarter?
HitIQ Limited released its earnings results on Feb 26, 2026. The company reported -AU$0.006 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.006.
Is HitIQ Limited overvalued?
According to Wall Street analysts HitIQ Limited’s price is currently Overvalued.
Does HitIQ Limited pay dividends?
HitIQ Limited does not currently pay dividends.
What is HitIQ Limited’s EPS estimate?
HitIQ Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does HitIQ Limited have?
HitIQ Limited has 756,219,300 shares outstanding.
What happened to HitIQ Limited’s price movement after its last earnings report?
HitIQ Limited reported an EPS of -AU$0.006 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 7.143%.
Which hedge fund is a major shareholder of HitIQ Limited?
Currently, no hedge funds are holding shares in AU:HIQ
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
HitIQ Limited Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:HIQ Sentiment 100%
Sector Average ―
Sector Average ―
Insider Transactions
Bought Shares
Worth AU$13.7K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-19.23%
12-Months-Change
Fundamentals
Return on Equity
152.58%
Trailing 12-Months
Asset Growth
-61.76%
Trailing 12-Months
Company Description
HitIQ Limited
HITIQ Limited is an Australian enterprise focused on developing and commercializing advanced technology for concussion management. Its Nexus software platform delivers comprehensive data and analytical insights concerning head impacts, empowering informed decision-making to enhance care for athletes. The company also offers CoVR, a virtual reality-based system for assessing cognitive and oculomotor functions, capable of identifying impairments in areas such as hand-eye coordination, memory, and critical thinking. Additionally, CSX provides a straightforward sideline tool for concussion evaluation, generating digital records that can be easily shared with medical professionals, family members, and organizations to ensure coordinated athlete support. Established in 2015, the company maintains its headquarters in Melbourne, Australia.
Technical Analysis
Resonance Health Ltd
―
Global Health Limited
―
Singular Health Group Ltd
―
Emyria Ltd
―
InteliCare Holdings Limited
―
Options Prices
Currently, No data available
---